(Q47231231)

English

Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome (English)

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

endometrial carcinoma

1 reference

based on heuristic

inferred from title

author name string

Peiró G

1

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

Mayr D

2

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

Hillemanns P

3

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

Löhrs U

4

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

Diebold J

5

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

publication date

1 March 2004

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

Modern Pathology

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

17

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

3

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

227-287

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

describes a project that uses

fluorescence in situ hybridization

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1038/modpathol.3800006

0 references

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Defining a test for HER-2/neu evaluation in breast cancer in the diagnostic setting.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

21 January 2018

The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification and expression of the c-erbB-2 oncogene in normal, hyperplastic, and malignant endometria

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu amplification and overexpression in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800006

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.3800006

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/14752523

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47231231&oldid=2147153123"